Laboratorios Bagó S.A.

What Laboratorios Bagó S.A. does

Laboratorios Bagó S.A. is a private Latin American pharmaceutical laboratory headquartered in Buenos Aires, Argentina, operating as the parent of Grupo Bagó with entities in Peru (Laboratorios Bagó del Perú S.A., founded 1997), Chile (Laboratorio Bagó de Chile S.A.), and additional Latin American markets. The Group employs approximately 7,000 people across seven countries, with the Peru subsidiary employing over 200 professionals from its regional headquarters in Miraflores, Lima. The company develops, manufactures, and markets prescription and over-the-counter pharmaceutical, biological, dermatological, and nutritional products under GMP-certified manufacturing processes, holding 148 product patents across more than 28 countries. Its portfolio includes bioequivalent formulations designed for therapeutic equivalence to reference medicines, alongside inclusive product design features such as Braille labels, sugar-free, gluten-free, and child-safe packaging.

The company operates a sales-led go-to-market through a network of trained medical representatives engaging healthcare professionals and pharmacy distribution channels, supplemented by a dedicated physician access portal (medicos.bago.com.pe) and sponsorship of medical congresses. Distribution spans pharmacy chains, independent pharmacies, hospitals, and healthcare institutions across Peru and the broader Group footprint. Marketing is multi-channel, combining health and culture blogs, social media presence on Facebook, LinkedIn, Instagram, and YouTube, professional events, and patient support programs providing treatment-adherence guidance.

Revenue is generated through one-time product sales of prescription and OTC pharmaceuticals via pharmacy and hospital distribution; pricing is not publicly disclosed. The Group has accumulated regulatory and cultural credentials — including Empresa Segura certifications (Ministry of Women, 2013/2015/2017), ABE Good Employer (2024), multiple Great Place to Work certifications (2020–2021), and the Huella de Carbono Perú Third Star (2026) — supporting its positioning as an ethical, inclusive, and sustainable pharmaceutical operator in the region. A 2026 partnership with Universidad Peruana de Ciencias Aplicadas (UPC) for the Hackathon Desafío IA Bago Perú indicates early exploration of AI applications in health.

Name

Laboratorios Bagó S.A.

Legal name

Laboratorios Bagó del Perú S.A.

Website

https://bago.com.pe

Company type

Private

Founded year

1997

Operating status

Operating

Short description

Laboratorios Bagó is a Latin American pharmaceutical laboratory group operating across seven countries, manufacturing prescription and OTC pharmaceutical, biological, dermatological, and nutritional products distributed through pharmacy networks, hospitals, and medical representatives to patients and healthcare professionals.

Ownership category

akta.pro rank

Product category

Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Biological Products, (No Disgnostic Substances) (2836), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Drug Product Fill-Finish & Aseptic Manufacturing Services (HLAAAKAB)

akta.pro secondary industries

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)

Keywords

• Prescription pharmaceuticals
• Over-the-counter medicines
• Bioequivalent generics
• Dermatology products
• Nutritional supplements

Headquarters

HQ city

Miraflores

HQ country

Peru

HQ region

Latin America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Sale of prescription and over-the-counter pharmaceutical products through pharmacy and hospital distribution networks

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Laboratorios Bagó S.A. develops, manufactures, and markets more than 200 prescription and over-the-counter pharmaceutical, biological, dermatological, and nutritional products across Peru, backed by 148 product patents in 28+ countries, GMP-certified manufacturing, bioequivalent formulations, and a pharmacovigilance system. Products are sold through pharmacy chains, hospitals, and a field force of medical representatives engaging healthcare professionals.

Product overview

Laboratorios Bagó S.A. is a pharmaceutical company offering a portfolio of prescription and over-the-counter pharmaceutical products. The product range includes bioequivalent medicines, sugar-free products, and gluten-free formulations. Products are categorized as either requiring medical prescription or available without prescription, with a focus on quality, efficacy, and safety standards.

Differentiator

Problem solved

Functional benefit

Brands

• Anaflex Mujer: Pain relief product for menstrual discomfort with messaging against violence towards women and empowerment of young women.
• Bagó Plus
• Campus Bagó

Products and services

• Productos Sin Receta (Over-the-Counter Pharmaceutical Products) Over-the-counter pharmaceutical products available for purchase without a medical prescription, sold through pharmacy distribution networks across Peru.
• Productos con Receta (Prescription Pharmaceutical Products) Prescription pharmaceutical products requiring a medical prescription for purchase, sold through pharmacy distribution networks and direct hospital and healthcare institution sales.

Quantifiable outcome

• 94% of team feels Bagó Peru provides hospitality
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Universidad Peruana de Ciencias Aplicadas (UPC)coreStrategic or Co-development Partner · 15 June 2026Partnership through Hackathon Desafio IA Bago Peru 2026, an initiative to promote solutions using artificial intelligence for health challenges in Peru. The collaboration brought together young talents to create innovative solutions.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• EMS Pharma: Brazil's largest generics manufacturer with a leading bioequivalent/generic portfolio. Comparable as a high-volume LatAm pharmaceutical manufacturer competing for pharmacy shelf space and bioequivalent tenders.
• Eurofarma: Brazil's largest multinational pharmaceutical company with branded generics, prescription, and OTC products across Latin America. Directly comparable as a regional pharma manufacturer with GMP operations and similar bioequivalent/generic strategy.
• Gador: Argentine pharmaceutical manufacturer with branded generics and specialty prescription products distributed across Latin America. Highly comparable profile to Bagó in therapeutic mix, geographic reach, and sales-led commercial model.
• Genomma Lab Internacional: Mexican-headquartered LatAm pharma company focused on OTC consumer healthcare brands across the region. Comparable OTC consumer health portfolio and pharmacy-channel-first distribution strategy.
• Aché Laboratórios: Brazilian pharmaceutical company with prescription, OTC, and generics portfolio and growing LatAm presence. Comparable in therapeutic breadth, sales-led model targeting physicians, and pharmacy distribution channels.
• Roemmers: Argentina-headquartered pharmaceutical laboratory with a comparable branded prescription and OTC portfolio across Latin America. Closest direct peer: similar company size, Argentine origin, GMP-certified manufacturing, and multi-country LatAm footprint.

Broad incumbents

• Pfizer: Global pharmaceutical leader with significant LatAm presence across both innovative and off-patent medicines. Competes with Bagó in prescription categories and increasingly in biosimilars/bioequivalents.
• Sanofi: Global pharmaceutical major with established prescription and consumer healthcare operations across Latin America. Overlaps with Bagó in selected therapeutic areas and OTC categories but at much larger scale and broader portfolio.
• Bayer (consumer health and pharma): Global pharmaceutical and consumer health major with deep presence across Latin America. Competes with Bagó in prescription and OTC categories, but operates at vastly larger scale and as part of a much broader global portfolio.

Regional players

• Laboratorio Chile (Teva presence): Chile-based pharmaceutical manufacturer with broad prescription and OTC portfolio. Comparable as a regional LatAm pharma manufacturer with overlapping product categories and pharmacy distribution channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@bagodelperu
• Facebookfacebook.com/LaboratoriosBagoPeru
• LinkedInlinkedin.com/company/laborat-rios-bag-do-brasil-s.a
• Instagraminstagram.com/laboratoriosbagodelperu

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratorios Bagó S.A.